欧洲急性胰腺炎市场预测至 2030 年 – 区域分析 – 按产品(药物、诊断等)、病因(胆结石、酗酒、遗传性疾病、感染等)和最终用户(医院、诊断实验室、门诊手术中心等)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 113    |    Report Code: BMIRE00029223    |    Category: Life Sciences

Europe Acute Pancreatitis Market

2022年欧洲急性胰腺炎市场价值为14.921亿美元,预计到2030年将达到22.6069亿美元;预计 2022 年至 2030 年复合年增长率为 5.3%。

急性胰腺炎后糖尿病发病率上升推动欧洲急性胰腺炎市场

胰腺产生胰岛素,这是一种调节血糖水平的激素。胰腺炎会损害胰腺产生胰岛素的细胞,从而导致急性胰腺炎患者患糖尿病。患有急性胰腺炎的人患糖尿病的风险是普通人群的两倍。急性胰腺炎的各种严重程度都会出现糖尿病后遗症,并且可能伴随其他临床并发症。

根据 2022 年发表的《欧洲医学和药理学科学评论》,胰源性糖尿病的患病率为 5–10在西方糖尿病人群中,慢性胰腺炎占20%,急性胰腺炎占80%。根据 2021 年国家医学图书馆发表的一篇文章,约 23% 的急性胰腺炎患者可能在出院三年内患上糖尿病。此外,2020 年《胃肠病学杂志》上发表的一篇文章指出,急性胰腺炎后,约 3%、7%、9% 和 11% 的患者在出院 6、12、18 和 24 个月时分别发展为糖尿病。根据 MDPI 发表的一篇文章,到 2023 年,约 40% 的急性胰腺炎患者受到糖尿病前期和糖尿病的影响,死亡和再入院的风险比 2 型糖尿病患者更高。此外,大约 60.2% 的成人患者在急性胰腺炎后发展为糖尿病,9% 的儿童在急性复发性胰腺炎或慢性胰腺炎后发展为糖尿病,而且这种风险随着年龄的增长而增加。研究人员在一项比较重症和轻度急性胰腺炎的荟萃分析中发现,重症急性胰腺炎后糖尿病的发病率(约 39%)高于轻度急性胰腺炎(14%)。因此,急性胰腺炎患者或康复患者中糖尿病发病率的增加有助于欧洲急性胰腺炎市场的增长。

欧洲急性胰腺炎市场概览

<欧洲急性胰腺炎市场分为德国、英国、法国、意大利、西班牙、北欧国家、荷兰和欧洲其他国家。德国和英国等国家预计将成为该地区市场的最大贡献者。急性胰腺炎患病率的上升和酒精消费的增加是推动欧洲市场增长的主要因素。根据联邦统计局的数据,2019年德国的医疗支出达4600.3亿美元。由于其创新的医疗保健方法,对于提供急性胰腺炎治疗产品的公司来说,这是一个有吸引力的市场。德国的医疗器械制造商还可以为各种研究项目寻求政府资助,并获得德国复兴信贷银行 (KfW) 的资助。制造商越来越关注新产品开发和战略合作,以开发急性胰腺炎等先进诊断设备,预计将进一步推动未来几年的市场增长。

欧洲急性胰腺炎市场收入和到 2030 年的预测(百万美元)

欧洲急性胰腺炎市场细分

欧洲急性胰腺炎市场的产品、原因、最终用户

和国家。

根据产品,欧洲急性胰腺炎市场分为药物、诊断等。 2022年诊断细分市场占据最大市场份额。

根据方法,欧洲急性胰腺炎市场分为胆结石、酗酒、遗传性疾病、感染等。 2022年,胆结石细分市场占据最大的市场份额。

根据最终用户,欧洲急性胰腺炎市场分为医院、诊断实验室、门诊手术中心等。 2022 年,医院细分市场占据最大的市场份额。

根据国家/地区,欧洲急性胰腺炎市场分为英国、德国、法国、意大利、西班牙、北欧国家、荷兰和欧洲其他地区。 2022 年,德国在欧洲急性胰腺炎市场份额中占据主导地位。

雅培 (Abbott Laboratories)、Actim Oy、百特国际公司 (Baxter International Inc)、波士顿科学公司 (Boston Scientific Corp)、Dynavax Technologies Corp、Fresenius Kabi AG、GE HealthCare Technologies Inc、Koninklijke Philips NV、美敦力 (Medtronic) Plc 和三星医疗保健是欧洲急性胰腺炎市场上的一些领先公司。



Europe Acute Pancreatitis Strategic Insights

Strategic insights for Europe Acute Pancreatitis involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-acute-pancreatitis-market-strategic-framework.webp
Get more information on this report

Europe Acute Pancreatitis Report Scope

Report Attribute Details
Market size in 2022 US$ 1,492.10 Million
Market Size by 2030 US$ 2,260.69 Million
Global CAGR (2022 - 2030) 5.3%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 供品
  • 药物
  • 诊断
By 原因
  • 胆结石
  • 酒精中毒
  • 遗传性疾病
  • 感染
By 最终用户
  • 医院
  • 诊断实验室
  • 门诊手术中心
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • Abbott Laboratories
  • Actim Oy
  • Baxter International Inc
  • Boston Scientific Corp
  • Dynavax Technologies Corp
  • Fresenius Kabi AG
  • GE HealthCare Technologies Inc
  • Koninklijke Philips NV
  • Medtronic Plc
  • Samsung Healthcare
  • Get more information on this report

    Europe Acute Pancreatitis Regional Insights

    The regional scope of Europe Acute Pancreatitis refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-acute-pancreatitis-market-geography.webp
    Get more information on this report

    The List of Companies - Europe Acute Pancreatitis Market

    1. Abbott Laboratories
    2. Actim Oy
    3. Baxter International Inc
    4. Boston Scientific Corp
    5. Dynavax Technologies Corp
    6. Fresenius Kabi AG
    7. GE HealthCare Technologies Inc
    8. Koninklijke Philips NV
    9. Medtronic Plc
    10. Samsung Healthcare
    Frequently Asked Questions
    How big is the Europe Acute Pancreatitis Market?

    The Europe Acute Pancreatitis Market is valued at US$ 1,492.10 Million in 2022, it is projected to reach US$ 2,260.69 Million by 2030.

    What is the CAGR for Europe Acute Pancreatitis Market by (2022 - 2030)?

    As per our report Europe Acute Pancreatitis Market, the market size is valued at US$ 1,492.10 Million in 2022, projecting it to reach US$ 2,260.69 Million by 2030. This translates to a CAGR of approximately 5.3% during the forecast period.

    What segments are covered in this report?

    The Europe Acute Pancreatitis Market report typically cover these key segments-

  • 供品 (药物, 诊断)
  • 原因 (胆结石, 酒精中毒, 遗传性疾病, 感染)
  • 最终用户 (医院, 诊断实验室, 门诊手术中心)
  • What is the historic period, base year, and forecast period taken for Europe Acute Pancreatitis Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Acute Pancreatitis Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Europe Acute Pancreatitis Market?

    The Europe Acute Pancreatitis Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott Laboratories
  • Actim Oy
  • Baxter International Inc
  • Boston Scientific Corp
  • Dynavax Technologies Corp
  • Fresenius Kabi AG
  • GE HealthCare Technologies Inc
  • Koninklijke Philips NV
  • Medtronic Plc
  • Samsung Healthcare
  • Who should buy this report?

    The Europe Acute Pancreatitis Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Acute Pancreatitis Market value chain can benefit from the information contained in a comprehensive market report.